Michael Holston - Merck Insider

Executive Vice President Chief Ethics and Compliance Officer

Mr. Michael J. Holston is Executive Vice President, General Counsel of Merck Co Inc. with effect from July 1, 2015
Age: 52  President Since 2015      
908 735-1500  www.merck.com
Michael Holston EducationHolston most recently served as executive vice president and general counsel for HewlettPackard Company, where he oversaw compliance, government affairs, privacy, ethics operations and legal affairs. Prior to his role with HewlettPackard, Holston was a partner in the litigation practice at Morgan, Lewis & Bockius LLP, where he served as external counsel to Merck on matters such as product litigation, government investigations and compliance with healthcare laws and regulations. Before joining Morgan Lewis, he served as a prosecutor in the criminal division of the U.S. Attorney Office for the Eastern District of Pennsylvania. Holston received his J.D. from Villanova University School of Law, Villanova, Penn. and a B.S.M.E. from the University of Notre Dame, South Bend, Indiana. He also is a fellow in the American College of Trial Lawyers.

Management Efficiency

The company has Return on Asset of 0.06 % which means that on every $100 spent on asset it made $0.06 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 6.9 % implying that it generated $6.9 on every 100 dollars invested.
The company has 26.41 B in debt with debt to equity (D/E) ratio of 0.57 which is OK given its current industry classification. Merck Co Inc has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives


Joseph LaRosaRegeneron Pharmaceuticals Inc
Diarmaid CunninghamICON Public Limited Company
Barry FlannellyIncyte Corporation
Garret HamptonIllumina Inc
David HastingsIncyte Corporation
Kevin KnightlyQuintiles Transnational Holding
William RobertsRegeneron Pharmaceuticals Inc
Pamela MurphyIncyte Corporation
Jay MarkowitzRegeneron Pharmaceuticals Inc
Wenqing YaoIncyte Corporation
David GryskaIncyte Corporation
George YancopoulosRegeneron Pharmaceuticals Inc
Eric SiegelIncyte Corporation
James ErlingerQuintiles Transnational Holding
Sanjay ChikarmaneIllumina Inc
Peter PowchikRegeneron Pharmaceuticals Inc
Daniel PlewRegeneron Pharmaceuticals Inc
Mostafa RonaghiIllumina Inc
Nicholas NaclerioIllumina Inc
Raymond LowSciClone Pharmaceuticals Inc
Michael AbermanRegeneron Pharmaceuticals Inc

Entity Summary

Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare with concentration in Pharmaceuticals And Biosciences.

Did you try this?

Run Pattern Recognition Now

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
Hide  View All  Next  Launch Pattern Recognition
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Merck Co Inc to your portfolio

Top Management

Merck Co Inc Leadership Team
Thomas Glocer, Director
C Kidder, Director
Craig Thompson, Director
Rochelle Lazarus, Director
Michael Rosenblatt, President, Ph.D
Wendell Weeks, Director
Michael Holston, President
Paul Rothman, Director
Adele Ambrose, President
Joseph Romanelli, Executive
Mirian GraddickWeir, President, Ph.D
Peter Wendell, Director
Leslie Brun, Director
Julie Gerberding, President
Pamela Craig, Director, MBA
Patricia Russo, Director
Willie Deese, President
Rita Karachun, SVP
Robert Davis, CFO
Robert Kidder, Director
Thomas Cech, Director, Ph.D
Clark Golestani, EVP
William Harrison, Director
Bruce Kuhlik, EVP
Roger Perlmutter, President, Ph.D
Sanat Chattopadhyay, President
Adam Schechter, President
Carlos Represas, Director
Cuong Do, President
Richard DeLuca, President
Kenneth Frazier, Chairman
Robert JD, CFO
Bridgette Heller, President

Stock Performance

Merck Performance Indicators